Exploratory bioinformatics study of lncRNAs in Alzheimer's disease mRNA sequences with application to drug development

Computational and Mathematical Methods in Medicine

Volumn 2013, Issue , 2013, Pages

  Holden, T ^a   Nguyen, A ^a   Lin, E ^b   Cheung, E ^a   Dehipawala, S ^a   Ye, J ^a   Tremberger, G ^a   Lieberman, D ^a   Cheung, T ^a  

^a QUEENSBOROUGH COMMUNITY COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SIGNALING; DNA SEQUENCES; FINITE DIFFERENCE METHOD; FRACTAL DIMENSION; GENES; GLYCOPROTEINS;

ALZHEIMER'S DISEASE; COMPARATIVE STUDIES; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ERYTHROPOIETIN (EPO); GLYCOPROTEIN HORMONES; PANCREATIC CANCERS; SEQUENCE ANALYSIS;

NEURODEGENERATIVE DISEASES;

APOLIPOPROTEIN E; ERYTHROPOIETIN; LONG UNTRANSLATED RNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; OREXIN; 5' NUCLEOTIDASE; AMYLOID PRECURSOR PROTEIN; EPO PROTEIN, HUMAN; ERYTHROPOIETIN RECEPTOR; GLYCOPROTEIN; NEUROPEPTIDE; NT5C3 PROTEIN, HUMAN; OREXIN RECEPTOR; OREXINS; PRESENILIN 2; PSEN2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ALZHEIMER DISEASE; ARTICLE; BIOINFORMATICS; CANCER CELL; DNA SEQUENCE; ENTROPY; GENE INTERACTION; HUMAN; HYPOTHALAMUS; NONHUMAN; PANCREAS CANCER; RNA SEQUENCE; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; ZEBRA FISH; ANIMAL; BIOLOGY; DISEASE MODEL; DRUG DEVELOPMENT; FRACTAL ANALYSIS; GENETICS; MOUSE; SEQUENCE ANALYSIS; STATISTICS; STATISTICS AND NUMERICAL DATA;

5'-NUCLEOTIDASE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; ERYTHROPOIETIN; FRACTALS; GLYCOPROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEUROPEPTIDES; OREXIN RECEPTORS; PRESENILIN-2; RECEPTORS, ERYTHROPOIETIN; RNA, LONG NONCODING; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; ZEBRAFISH;

EID: 84877267531     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1155/2013/579136     Document Type: Article

References (27)

1. Tremberger G. Jr., Dehipawala S., Cheung E., Yao H., Gadura N., Schneider P., Lieberman D., Holden T., Cheung T., Fractal analysis of FOXP2 regulated accelerated conserved non-coding sequences in human fetal brain. World Academy of Science, Engineering and Technology 2012 67 881 886
2. Khaitan D., Dinger M. E., Mazar J., Crawford J., Smith M. A., Mattick J. S., Perera R. J., The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Research 2011 71 11 3852 3862 2-s2.0-79957907741 10.1158/0008-5472.CAN-10-4460
3. Ozgür E., Mert U., Isin M., Okutan M., Dalay N., Gezer U., Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clinical and Experimental Medicine 2012 10.1007/s10238-012-0181-x
4. Han L., Zhang K., Shi Z., Zhang J., Zhu J., Zhu S., Zhang A., Jia Z., Wang G., Yu S., Pu P., Dong L., Kang C., LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. International Journal of Oncology 2012 40 6 2004 2012
5. Clark M. B., Johnston R. L., Inostroza-Ponta M., Fox A. H., Fortini E., Moscato P., Dinger M. E., Mattick J. S., Genome-wide analysis of long noncoding RNA stability. Genome Research 2012 22 5 885 898
6. Johnson R., Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiology of Disease 2011 46 2 245 254
7. Niland C. N., Merry C. R., Khalil A. M., Emerging roles for long non-coding RNAs in cancer and neurological disorders. Frontiers in Genetics 2012 3, article 25
8. Moran V. A., Perera R. J., Khalil A. M., Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Research 2012 40 14 6391 6400
9. Qi P., Du X., The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern Pathology 2012 26 155 165 10.1038/modpathol.2012. 160
10. Niazi F., Valadkhan S., Computational analysis of functional long noncoding RNAs reveals lack of peptide-coding capacity and parallels with 3' UTRs. RNA 2012 18 4 825 843
11. Tahira A. C., Kubrusly M. S., Faria M. F., Dazzani B., Fonseca R. S., Maracaja-Coutinho V., Verjovski-Almeida S., Machado M. C., Reis E. M., Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Molecular Cancer 2011 10 1 19
12. Higuchi T., Approach to an irregular time series on the basis of the fractal theory. Physica D 1988 31 2 277 283 2-s2.0-45549113571
13. Holden T., Subramaniam R., Sullivan R., ATCG nucleotide fluctuation of deinococcus radiodurans radiation genes. Proceedings of SPIE 2007 6694 10 669417
14. Holden T., Tremberger G. Jr., Marchese P., Cheung E., Subramaniam R., Sullivan R., Schneider P., Flamholz A., Lieberman D., Cheung T., DNA sequance based comparative studies of between non-extremophile and extremophile organisms with implications in exobiology. Proceedings of SPIE 2008 12 70970Q
15. Fronczek R., van Geest S., Frölich M., Overeem S., Roelandse F. W., Lammers G. J., Swaab D. F., Hypocretin (orexin) loss in Alzheimer's disease. Neurobiology of Aging 2012 33 8 1642 1650
16. Reiman Eric M., Quiroz Y. T., Fleisher A. S., Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurology 2012 11 12 1048 1056
17. Marti H. H., Erythropoietin and the hypoxic brain. The Journal of Experimental Biology 2004 207 part 18 3233 3242 (Pubitemid 39275297)
18. Kanaan N. M., Collier T. J., Marchionini D. M., McGuire S. O., Fleming M. F., Sortwell C. E., Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Research 2006 1068 1 221 229 2-s2.0-31344465984 10.1016/j.brainres.2005.10.078 (Pubitemid 43139281)
19. Alnaeeli M., Wang L., Piknova B., Rogers H., Li X., Noguchi C. T., Erythropoietin in brain development and beyond. Anatomy Research International 2012 2012 15 10.1155/2012/953264 953264
20. Sirén A. L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., Ghezzi P., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4044 4049 2-s2.0-0035957426 10.1073/pnas.051606598 (Pubitemid 32249895)
21. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T. R., Brines M., Ghezzi P., Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. Journal of Experimental Medicine 2003 198 6 971 975 2-s2.0-0141784841 10.1084/jem.20021067 (Pubitemid 37152934)
22. Athavale S. S., Petrov A. S., Hsiao C., RNA folding and catalysis mediated by iron (II). PLoS One 2012 7 5 7 e38024
23. Pauli A., Valen E., Lin M. F., Garber M., Vastenhouw N. L., Levin J. Z., Fan L., Sandelin A., Rinn J. L., Regev A., Schier A. F., Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Research 2012 22 3 577 591
24. Jonsson T., Stefansson H., Steinberg S., Variant of TREM2 associated with the risk of Alzheimer's disease. The New England Journal of Medicine 2013 368 2 107 116
25. Guerreiro R., Wojtas A., Bras J., TREM2 variants in Alzheimer's disease. The New England Journal of Medicine 2013 368 2 117 127
26. Neumann H., Daly M. J., Variant TREM2 as risk factor for Alzheimer's disease. The New England Journal of Medicine 2013 368 2 182 184
27. McVicar D. W., Trinchieri G., CSF-1R, DAP12 and beta-catenin: a ménage à trios. Nature Immunology 2009 10 7 681 683